Montefiore Einstein ranks as one of the nation’s best—again—in U.S. News & World Report’s rankings for 2023–2024, placing in the top 1% percent of hospitals for complex specialty care in cancer, cardiology & heart surgery, diabetes & endocrinology, and orthopedics.
Out of more than 6,000 hospitals in the United States, our diabetes and endocrinology care ranks #31 nationally; cardiology and heart surgery advanced two positions to #31; cancer ranks #35; and orthopedics ranks #46 nationally.
Montefiore Einstein’s complex specialty care in gastroenterology and gastrointestinal (GI) surgery, geriatrics, neurology & neurosurgery, pulmonology & lung surgery, and urology were recognized as High Performing, placing it among the top providers in the country.
Additionally, Montefiore Einstein achieved High Performing designations for the following procedures and conditions: aortic valve surgery, chronic obstructive pulmonary disease (COPD), colon cancer surgery, diabetes, heart attack, heart failure, hip fracture, kidney failure, leukemia, lymphoma & myeloma, lung cancer surgery, pneumonia, stroke, and uterine cancer surgery.
